article thumbnail

Young Pharmaceuticals Opens New Global Headquarters

MedEsthetics

young pharmaceuticals, global expansion, new global headquarters, John Kulesza, skin care products, skin care, business, business expansion, medical aesthetics, dermatologic products

article thumbnail

Medical Grade Skincare vs. Over-the-Counter Products: What’s the Difference?

Kim Gallo Esthetics

Are you wondering what the difference is between medical-grade skincare products and over-the-counter products? In this blog post, we will discuss the key differences between medical-grade skincare and over-the-counter products - so you can decide which route is best for you. What is medical-grade skincare?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ligand Pharmaceuticals Launches Pelthos to Accelerate Commercialization of Zelsuvmi for Molluscum; Appoints New CEO

The Dermatology Digest

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. in September 2023.

article thumbnail

Pelage Pharmaceuticals Announces $16.75M Series A Financing to Advance Hair Loss Treatment

The Dermatology Digest

Pelage Pharmaceuticals has closed a $16.75 We have uncovered a small molecule able to stimulate cellular metabolism to re-awaken hair follicle stem cells and spur new hair growth,” says William Lowry, PhD, scientific co-founder, Pelage Pharmaceuticals, in a news release. In addition to her clinical expertise, Dr. .

article thumbnail

News You Can Use: Verrica Receives Permanent J-Code for YCANTH 

The Dermatology Digest

Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In J-codes are a type of HCPCS Level II code commonly used to designate non-orally administered drugs and other medical devices.

article thumbnail

There Are So Many Skincare Lines– Is One Better Than Another?

Renee Rouleau

Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. Even Botox, popular in the modern day for smoothing fine lines and plumping the skin, was first used as a treatment for Parkinson’s.

Skincare 195
article thumbnail

Warts and All: Verrica and Torii Team Up to Fund Global Phase 3 Trial of YCANTH for Common Warts

The Dermatology Digest

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. FDA and Japan’s Pharmaceuticals and Medical Device Agency (PMDA) on the proposed design of the Phase 3 clinical trial. With a prevalence of approximately 22 million patients in the U.S.